Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · February 03, 2024

Intraperitoneal PD-1 Monoclonal Antibody for Advanced Primary Liver Cancer With Malignant Ascites



Additional Info

Intraperitoneal PD-1 monoclonal antibody for the treatment of advanced primary liver cancer with malignant ascites: a single-arm, single-center, phase Ib trial
ESMO Open 2024 Jan 08;9(1)102206, C Chen, Z Li, X Xiong, A Yao, S Wang, X Liu, X Liu, J Wang

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading